AI assistant
Sending…
Altimmune, Inc. — Director's Dealing 2010
Jun 24, 2010
33207_dirs_2010-06-24_74e020da-bbb9-437d-a79d-b0abbc2f3bf1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2010-06-23
Reporting Person: CAVANAUGH JAMES H (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-06-23 | Option (Right to Buy) | $1.60 | A | 20000 | Acquired | 2020-06-23 | Common Stock (20000) | Direct |
More from Altimmune, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 17
Proxy Solicitation & Information Statement
2026
Mar 17
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 6